What is NDC 60846-559?

60846-559 is the product NDC for Pyridostigmine bromide, Pyridostigmine bromide 105 mg/1 tablet, extended release, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals LLC, NDC labeler code 60846. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pyridostigmine bromide?

17 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pyridostigmine bromide NDC 60846-559 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60846-559Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60846-0559Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60846-559-10	60846055910	10 CARTON in 1 BAG (60846-559-10) / 1 BLISTER PACK in 1 CARTON (60846-559-27) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Oct 9, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pyridostigmine bromide
Generic name (nonproprietary): pyridostigmine bromide
Active ingredients: Pyridostigmine bromide — 105 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Amneal Pharmaceuticals LLCNDC labeler code 60846
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 217604
Marketing start: Oct 9, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 60846-559_d6813c89-ca7b-4495-86ac-137a38854371SPL ID d6813c89-ca7b-4495-86ac-137a38854371SPL set ID 52d6f195-165a-400b-a13b-489e94bcf0b0RxCUI 2695047UNII KVI301NA53UPC 0360846559279, 0360846559101
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460846055910 followed by a unit qualifier and the quantity

Package 60846-0559-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Pyridostigmine bromide is indicated for pretreatment against the lethal effects of soman nerve agent poisoning in adults. Pyridostigmine bromide is intended for use in conjunction with protective garments, including a mask. At the first sign of nerve agent poisoning, pyridostigmine bromide should be stopped, and atropine and pralidoxime therapy started immediately. The evidence for the effectiveness of pyridostigmine bromide as pretreatment against soman-induced toxicity was derived from animal studies alone [see Clinical Studies (14) ]. FOR MILITARY MEDICAL USE ONLY Pyridostigmine bromide is a cholinesterase inhibitor indicated for pretreatment against the lethal effects of soman nerve agen…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60846-559

What is NDC 60846-559?: 60846-559 is the product NDC for Pyridostigmine bromide, Pyridostigmine bromide 105 mg/1 tablet, extended release, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pyridostigmine bromide.
What is the active ingredient?: Pyridostigmine bromide.
Who is the labeler?: Amneal Pharmaceuticals LLC, NDC labeler code 60846. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pyridostigmine bromide?: 17 other product NDCs are listed under this name. See all Pyridostigmine bromide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pyridostigmine bromide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/1	TabletOral	Method Pharmaceuticals, LLC	58657-811	58657-0811-0158657-0811-3058657-0811-90
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-470	62559-0470-01
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/5mL	SolutionOral	Acella Pharmaceuticals, LLC	42192-626	42192-0626-16
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/5mL	SolutionOral	Novadoz Pharmaceuticals LLC	72205-098	72205-0098-72
Pyridostigmine Bromide	Pyridostigmine bromide 30 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-2134	00115-2134-01
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/5mL	SolutionOral	Amneal Pharmaceuticals NY LLC	69238-1731	69238-1731-02
Pyridostigmine Bromide	Pyridostigmine bromide 60 mg/5mL	SolutionOral	VistaPharm, LLC	66689-406	66689-0406-10
Pyridostigmine Bromide	Pyridostigmine bromide 30 mg/1	TabletOral	Method Pharmaceuticals, LLC	58657-810	58657-0810-21
Pyridostigmine Bromide	Pyridostigmine bromide 180 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-220	64980-0220-03
pyridostigmine bromide	Pyridostigmine bromide 60 mg/1	TabletOral	Major Pharmaceuticals	0904-6622	00904-6622-5900904-6622-61

All 18 Pyridostigmine bromide NDCs